Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer

BACKGROUND: The novel water soluble compound STA-1474 is metabolized to ganetespib (formerly STA-9090), a potent HSP90 inhibitor previously shown to kill canine tumor cell lines in vitro and inhibit tumor growth in the setting of murine xenografts. The purpose of the following study was to extend th...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: London, Cheryl A., Bear, Misty D., McCleese, Jennifer, Foley, Kevin P., Paalangara, Reji, Inoue, Takayo, Ying, Weiwen, Barsoum, James
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3207826/
https://ncbi.nlm.nih.gov/pubmed/22073242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0027018
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires